The International Journal of Radiation Oncology*Biology*Physics, known as the Red Journal, is pleased to announce the top reviewers of 2016. Twenty-one reviewers made the list based on editor ratings of reviews, turnaround time and number of completed reviews.
Red Journal leadership owes a great deal to its reviewers, whose dedication and sense of volunteerism has helped establish the journal as the premier publication for radiation oncology.
“Our reviewers are the lifeblood of the journal,” said Anthony L. Zietman, MD, editor-in-chief of the Red Journal and a radiation oncologist at Massachusetts General Hospital in Boston. “Their time and expertise really help our authors and editors make each paper better. This in turn helps other radiation oncologists take better care of patients.”
For the Red Journal top reviewers, there are multiple reasons why they choose to review. Two of this year’s awardees, Jing Cai, PhD, and Masaharu Hata, MD, PhD, share their reasons.
“It is a great privilege to see these amazing works at least a few months earlier than the general readers,” said Dr. Cai, an associate professor of radiation oncology at Duke University in Durham, North Carolina. “It helps me to grasp the state-of-the-art research advances in a very effective and efficient manner, as well as to gain a better understanding of the requirements for high-quality research works and manuscript writing to publish in high-quality journals.”
The same sentiments are echoed by Dr. Hata: “I feel highly honored to review for the Red Journal, [which] is the most famous among all international journals that specialize in radiation oncology,” Dr. Hata said. “The manuscripts submitted to the Red Journal give me new and valuable knowledge even regarding my special field.” Hata practices at Yokohama City University Graduate School of Medicine in Japan.
Submissions to ASTRO’s journals continue to increase, especially as the Red Journal’s Impact Factor continues to climb. The Red Journal leadership recognizes that time and energy are finite resources and they are grateful for the Red Journal reviewers who have responded in kind to the increase in submissions.
Dr. Hata is a prolific reviewer primarily “because I have had my submitted manuscripts reviewed gratis by many faithful reviewers.” For Dr. Cai, it is a sense of obligation to further radiation oncology that keeps him engaged. “Sometimes it is because the topic of the study is closely related to my expertise and I feel I have the obligation to provide constructive comments to the authors that may help them to improve their studies or manuscripts.”
More than being an invaluable asset ensuring the Red Journal’s prominence, the journal’s reviewer pool also allows the Red Journal, as well as the two other ASTRO journals, Practical Radiation Oncology and Advances in Radiation Oncology, to refresh their editorial pools with new talent. This year, Dr. Cai is joining the Physics editorial group as an Associate Editor under Eric Klein, PhD. Similarly, another outstanding reviewer, Ralph Ermoian, MD, who practices at the University of Washington Medical Center and at the Seattle Cancer Care Alliance’s proton therapy center, is joining the Red Journal’s Pediatric Cancers editorial group currently led by Stephanie Terezakis, MD, MPH. Grace Li Smith, MD, PhD, is joining the Advances in Radiation Oncology editorial board as an associate editor.
We are always looking for more reviewers for all ASTRO journals. If you are interested in signing up to become a reviewer, please send an email to firstname.lastname@example.org. For residents and fellows, the Red Journal is offering the Resident Peer Review Training Program.
2016 Top Reviewers
- Christopher Anker, University of Vermont Cancer Center, Burlington, Vermont
- Rob Barnett, London Regional Cancer Program, London, Ontario, Canada
- Jing Cai, Duke University, Durham, North Carolina
- Laura Cella, National Research Council, Naples, Italy
- Jamie Adam Dean, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London
- Ralph P. Ermoian, University of Washington, Seattle
- Mirek Fatyga, Mayo Clinic Arizona, Phoenix
- Gregory Gan, University of New Mexico Cancer Center, Albuquerque, New Mexico
- Masaharu Hata, Yokohama City University Graduate School of Medicine, Yokohama, Japan
- Nataniel H. Lester-Coll, Yale University School of Medicine, New Haven, Connecticut
- Anna Likhacheva, Banner, MD Anderson Cancer Center, Gilbert, Arizona
- Vitali Moiseenko, University of California, San Diego, La Jolla, California
- James Murphy, University of California, San Diego, La Jolla, California
- Jasper Nijkamp, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
- Nitin Ohri, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York
- Joseph Salama, Duke University, Durham, North Carolina
- Timothy Showalter, University of Virginia, Charlottesville, Virginia
- Grace Li Smith, MD Anderson Cancer Center, Houston
- Daniel E. Spratt, University of Michigan Cancer Center, Ann Arbor, Michigan
- Kelly C. Younge, University of Michigan, Ann Arbor, Michigan
- Joachim Widder, University of Groningen, University Medical Center, Groningen, The Netherlands